Hou HL - Search Results

1

Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.

Wang HH, Deng L, Wen QL, Zhang CZ, Zaorsky NG, Zhang BL, Chen J, Zeng XL, Cui YL, Shi YY, Hou HL, Wang W, Jiang B, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P, Meng MB. Wang HH, et al. Among authors: hou hl. Oncotarget. 2017 May 23;8(38):62998-63013. doi: 10.18632/oncotarget.18071. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28968966 Free PMC article.

2

[Concurrent chemoradiotherapy for stage III non-small cell lung cancer].

Hou HL, Hao JL, Pang QS, Wang P. Hou HL, et al. Zhonghua Yi Xue Za Zhi. 2010 Aug 3;90(29):2068-70. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21029648 Clinical Trial. Chinese.

3

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy.

Zhuang H, Hou H, Yuan Z, Wang J, Pang Q, Zhao L, Wang P. Zhuang H, et al. Onco Targets Ther. 2014 May 24;7:807-13. doi: 10.2147/OTT.S62707. eCollection 2014. Onco Targets Ther. 2014. PMID: 24920921 Free PMC article.

4

Hou HL, Song YC, Li RY, Zhu L, Zhao LJ, Yuan ZY, You JQ, Chen ZJ, Wang P. Hou HL, et al. Med Sci Monit. 2015 Aug 3;21:2251-6. doi: 10.12659/MSM.893585. Med Sci Monit. 2015. PMID: 26235604 Free PMC article. Clinical Trial.

5

The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas.

Hou HL, Meng MB, Chen XL, Zhao LJ, Zhu L, Zhang BL, Wang P. Hou HL, et al. Onco Targets Ther. 2015 Aug 28;8:2339-44. doi: 10.2147/OTT.S88186. eCollection 2015. Onco Targets Ther. 2015. PMID: 26357482 Free PMC article.

6

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.

Chen Y, Liu W, Wang P, Hou H, Liu N, Gong L, Wang Y, Ji K, Zhao L, Wang P. Chen Y, et al. Oncotarget. 2016 Nov 1;7(44):71341-71352. doi: 10.18632/oncotarget.11217. Oncotarget. 2016. PMID: 27533085 Free PMC article.

7

High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer.

Hou H, Er P, Cheng J, Chen X, Ding X, Wang Y, Chen X, Yuan Z, Pang Q, Wang P, Qian D. Hou H, et al. Cancer Med. 2017 Aug;6(8):1871-1881. doi: 10.1002/cam4.1112. Epub 2017 Jul 18. Cancer Med. 2017. PMID: 28719148 Free PMC article.

8

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.

Wang Y, Cheng J, Xie D, Ding X, Hou H, Chen X, Er P, Zhang F, Zhao L, Yuan Z, Pang Q, Wang P, Qian D. Wang Y, et al. Cancer Commun (Lond). 2018 Jun 5;38(1):33. doi: 10.1186/s40880-018-0307-y. Cancer Commun (Lond). 2018. PMID: 29871674 Free PMC article.

9

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.

Chen Y, Liu W, Wang P, Hou H, Liu N, Gong L, Wang Y, Ji K, Zhao L, Wang P. Chen Y, et al. Oncotarget. 2018 Aug 3;9(60):31787. doi: 10.18632/oncotarget.25958. eCollection 2018 Aug 3. Oncotarget. 2018. PMID: 30167094 Free PMC article.

10

[Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].

Chen J, Cao YJ, Zhu L, Zhang BL, Liu ZY, Hou HL, Chai YL, Wang P. Chen J, et al. Among authors: hou hl. Zhonghua Yi Xue Za Zhi. 2021 Mar 2;101(8):597-601. doi: 10.3760/cma.j.cn112137-20201104-03011. Zhonghua Yi Xue Za Zhi. 2021. PMID: 33663192 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters